Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.

Epler K, Padilla D, Phillips G, Crowder P, Castillo R, Wilkinson D, Wilkinson B, Burgard C, Kalinich R, Townson J, Chackerian B, Willman C, Peabody D, Wharton W, Brinker CJ, Ashley C, Carnes E.

Adv Healthc Mater. 2012 May;1(3):348-53. doi: 10.1002/adhm.201200022.

2.

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN, Liu J, Phillips B, Carter MB, Carroll NJ, Jiang X, Dunphy DR, Willman CL, Petsev DN, Evans DG, Parikh AN, Chackerian B, Wharton W, Peabody DS, Brinker CJ.

Nat Mater. 2011 May;10(5):389-97. doi: 10.1038/nmat2992. Erratum in: Nat Mater. 2011 Jun;10(6):476.

3.

Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.

Butler KS, Durfee PN, Theron C, Ashley CE, Carnes EC, Brinker CJ.

Small. 2016 Apr 27;12(16):2173-85. doi: 10.1002/smll.201502119. Review.

PMID:
26780591
4.

Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.

Ashley CE, Carnes EC, Epler KE, Padilla DP, Phillips GK, Castillo RE, Wilkinson DC, Wilkinson BS, Burgard CA, Kalinich RM, Townson JL, Chackerian B, Willman CL, Peabody DS, Wharton W, Brinker CJ.

ACS Nano. 2012 Mar 27;6(3):2174-88. doi: 10.1021/nn204102q.

5.

Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.

Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ.

Acc Chem Res. 2013 Mar 19;46(3):792-801. doi: 10.1021/ar3000986.

6.

The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.

Wang D, Huang J, Wang X, Yu Y, Zhang H, Chen Y, Liu J, Sun Z, Zou H, Sun D, Zhou G, Zhang G, Lu Y, Zhong Y.

Biomaterials. 2013 Oct;34(31):7662-73. doi: 10.1016/j.biomaterials.2013.06.042.

PMID:
23859657
7.

Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles.

Liu J, Stace-Naughton A, Jiang X, Brinker CJ.

J Am Chem Soc. 2009 Feb 4;131(4):1354-5. doi: 10.1021/ja808018y.

8.

Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy.

Xuan M, Shao J, Dai L, He Q, Li J.

Adv Healthc Mater. 2015 Aug 5;4(11):1645-52. doi: 10.1002/adhm.201500129.

PMID:
25960053
9.

Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.

Cheng YJ, Luo GF, Zhu JY, Xu XD, Zeng X, Cheng DB, Li YM, Wu Y, Zhang XZ, Zhuo RX, He F.

ACS Appl Mater Interfaces. 2015 May 6;7(17):9078-87. doi: 10.1021/acsami.5b00752.

PMID:
25893819
10.

[Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].

Chen X, Zhang XX, Li FF, Zhao YN, Jia Z, Gan Y, Li J.

Yao Xue Xue Bao. 2014 May;49(5):718-25. Chinese.

PMID:
25151746
11.

Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.

Wu L, Wu M, Zeng Y, Zhang D, Zheng A, Liu X, Liu J.

Nanotechnology. 2015 Jan 16;26(2):025102. doi: 10.1088/0957-4484/26/2/025102.

PMID:
25517859
12.

Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake.

Cauda V, Engelke H, Sauer A, Arcizet D, Bräuchle C, Rädler J, Bein T.

Nano Lett. 2010 Jul 14;10(7):2484-92. doi: 10.1021/nl100991w.

PMID:
20515041
13.

Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy.

Zhang F, Braun GB, Pallaoro A, Zhang Y, Shi Y, Cui D, Moskovits M, Zhao D, Stucky GD.

Nano Lett. 2012 Jan 11;12(1):61-7. doi: 10.1021/nl202949y.

PMID:
22133237
14.

Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy.

Chen F, Hong H, Shi S, Goel S, Valdovinos HF, Hernandez R, Theuer CP, Barnhart TE, Cai W.

Sci Rep. 2014 May 30;4:5080. doi: 10.1038/srep05080.

15.

Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.

Yu M, Jambhrunkar S, Thorn P, Chen J, Gu W, Yu C.

Nanoscale. 2013 Jan 7;5(1):178-83. doi: 10.1039/c2nr32145a.

PMID:
23076766
16.

Vesicle adsorption on mesoporous silica and titania.

Claesson M, Cho NJ, Frank CW, Andersson M.

Langmuir. 2010 Nov 16;26(22):16630-3. doi: 10.1021/la102719w.

PMID:
20932045
17.

Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy.

Ma X, Qu Q, Zhao Y.

ACS Appl Mater Interfaces. 2015 May 27;7(20):10671-6. doi: 10.1021/acsami.5b03087.

PMID:
25974979
18.

Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia.

Lu F, Popa A, Zhou S, Zhu JJ, Samia AC.

Chem Commun (Camb). 2013 Dec 18;49(97):11436-8. doi: 10.1039/c3cc46658b.

PMID:
24169596
19.
20.

Dislocation of ricin toxin A chains in human cells utilizes selective cellular factors.

Redmann V, Oresic K, Tortorella LL, Cook JP, Lord M, Tortorella D.

J Biol Chem. 2011 Jun 17;286(24):21231-8. doi: 10.1074/jbc.M111.234708.

Items per page

Supplemental Content

Support Center